Submissions from 2024
One if By Hand, Two if Orally: PICCing the Best Treatment Option, Monica V. Mahoney and Christina F. Yen
Respiratory equality: let's stop playing favorites with COVID-19 in the healthcare setting, Catherine L. Passaretti, Werner Bischoff, Justin Chan, Daniel J. Diekema, Shira Doron, Carolee Estelle, Jesse T. Jacob, Tsun Sheng Ku, and Surbhi Leekha
Diagnostic stewardship to improve patient outcomes and healthcare-associated infection (HAI) metrics, Harjot K. Singh, Kimberly C. Claeys, Sonali D. Advani, Yolanda J. Ballam, Jessica Penney, Kirsten M. Schutte, Christopher Baliga, Aaron M. Milstone, Mary K. Hayden, Daniel J. Morgan, and Daniel J. Diekema
Submissions from 2023
Are contact precautions "essential" for the prevention of healthcare-associated methicillin-resistant Staphylococcus aureus?, Daniel J. Diekema, Priya Nori, Michael P. Stevens, Matthew W. Smith, K C. Coffey, and Daniel J. Morgan
Improving antimicrobial use through better diagnosis: The relationship between diagnostic stewardship and antimicrobial stewardship, Tsun Sheng Ku, Mayar Al Mohajer, James A. Newton, Marie H. Wilson, Elizabeth Monsees, Mary K. Hayden, Kevin Messacar, and Daniel J. Diekema
Reconsidering the routine use of contact precautions in preventing the transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in healthcare settings, Guillermo Rodriguez-Nava, Daniel J. Diekema, and Jorge L. Salinas
Investigating infectious outcomes in adult patients undergoing solid organ transplantation: A retrospective single-center experience, Paris, France, Hassan Tarhini, Rami Waked, Mayda Rahi, Nihel Haddad, Richard Dorent, Christine Randoux, Vincent Bunel, Sylvie Lariven, Laurene Deconinck, Christophe Rioux, Yazdan Yazdanpanah, Veronique Joly, and Jade Ghosn
Submissions from 2020
Code Blue in the COVID-19 Patient, Jeffrey A. Holmes
Differences in Naloxone Prescribing by Patient Age, Ethnicity, and Clinic Location Among Patients at High-Risk of Opioid Overdose., David Kispert, Jenny L Carwile, Kristen B Silvia, Elizabeth B Eisenhardt, and Kinna Thakarar
Rural-Urban Differences in Hospitalizations for Opioid Use-Associated Infective Endocarditis in the United States, 2003-2016., E Katherine Nenninger, Jenny L Carwile, Katherine A Ahrens, Brett Armstrong, and Kinna Thakarar
Limited Clinical Utility of Follow-up Blood Cultures in Patients With Streptococcal Bacteremia: An Opportunity for Blood Culture Stewardship., Emily A Siegrist, Minkey Wungwattana, Leyla Azis, Patricia Stogsdill, Wendy Craig, and Kristina E Rokas
Federal and State Action Needed to End the Infectious Complications of Illicit Drug Use in the United States: IDSA and HIVMA's Advocacy Agenda, Sandra A. Springer, Joshua A. Barocas, Alysse Wurcel, Ank Nijhawan, Kinna Thakarar, Ruth Lynfield, Hermione Hurley, Jessica Snowden, Alice Thornton, and Carlos Del Rio
An analysis of chronic hepatitis C management and cure rates at the Gilman Clinic in Portland, ME, from July to December 2018, Nicoleta Toma, Katy Garrett, and Kinna Thakarar
Submissions from 2013
Combating infections at Maine Medical Center: Insights into complexity-informed leadership from positive deviance, Curt Lindberg and Margaritte Schneider
Submissions from 2012
Payer-provider collaboration in accountable care reduced use and improved quality in Maine Medicare Advantage plan., Thomas F Claffey, Joseph V Agostini, Elizabeth N Collet, Lonny Reisman, and Randall Krakauer